Bio-Techne
Manufacturing · Minnesota, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
614 Mckinley Pl NE, Minneapolis, Minneso...Phone Number
(612) 379-2956Website
www.bio-techne.comRevenue
$1.2 BillionStock Symbol
TECHIndustry
About Bio-Techne
Bio-Techne Org Chart
Is Bio-Techne your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Bio-Techne
Check if Bio-Techne has recently received funding, and reach out quickly before it becomes old news!
Bio-Techne, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Bio-Techne had a recent Job posting/layoffs
Product Launch: Get notified when Bio-Techne launches new products
Check out if Bio-Techne is spiking on competitors!
Funding: Get notified immidiatlly once Bio-Techne has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Bio-Techne recently announced quarterly report
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Bio-Techne
Compare insights from companies similar to Bio-Techne, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Bio-Techne
Company Profile Activity
Activity Insights
Bio-Techne is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Bio-Techne is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Bio-Techne.
Bio-Techne Tech Stack
A closer look at the technologies used by Bio-Techne
Most Recent Scoops
Bio-Techne News & Media
Bio-Techne Releases Fourth Quarter Fiscal 2026 Results
MINNEAPOLIS, Aug. 12, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ending June 30, 2026. Fourth Quarter FY2026 Highlights Fourth quarter organic revenue increased by 3% (1% reported) to $321.2 million. Full year...Bio-Techne Declares Dividend
MINNEAPOLIS, Aug. 12, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended June 30, 2026. The quarterly dividend will be payable August 28, 2026, to all common shareholders...Investors’ Confidence in Bio-Techne Corp. (TECH) Strengthens as Headwind Eases
Conestoga Capital Advisors, an asset management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The letter reports a positive market shift towards Small Caps, with the Russell 2000 Index achieving its best first half since 1991 and the Russell 2000 Growth Index up 25.7% in Q2, fueled by AI […]Bio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein Portfolio
Advancing Scalable Reproducible Cell Therapy and Advanced Cell Culture Workflows New heat-stable and hyperactive proteins across the fibroblast growth factor and interleukin cytokine families expand the R&D Systems™ AI-Engineered Designer Protein portfolio AI-guided protein design...
Top Manufacturing Companies
Frequently Asked Questions Regarding Bio-Techne
Founded in 1981, Bio-Techne Corporation is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and prov... Read More
